On the stock market since 2017, it operates in the world of health and science. It has 25 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
If every debt were paid off today, $37.4M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
The price looks reasonable next to what the company earns.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 92% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $40.3M in the vault; even if every debt were paid off, $37.4M would remain.
Over the last 12 months, company executives reported 18 buys and 11 sells. Management buying with its own money is usually read as a good sign.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 16/100. For a turnaround signal, the stock first needs to close the gap with the market.
On our five-subject report card, SPRO sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: SPRO is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.